Beranda › Leukemia Mielomonositik Juvenil
Uji klinis Leukemia Mielomonositik Juvenil yang merekrut di AS
9 studi untuk Leukemia Mielomonositik Juvenil merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Philadelphia, PA4 studi
- Minneapolis, MN4 studi
- Boston, MA3 studi
- Seattle, WA3 studi
- Memphis, TN3 studi
- Cincinnati, OH3 studi
- Atlanta, GA3 studi
- Chicago, IL3 studi
- Washington, DC3 studi
- Ann Arbor, MI3 studi
- San Francisco, CA3 studi
- New York City, NY3 studi
- Indianapolis, IN3 studi
Berdasarkan negara bagian
- California3 studi
- Colorado3 studi
- Distrik Columbia3 studi
- Florida3 studi
- Georgia3 studi
- Illinois3 studi
- Indiana3 studi
- Massachusetts3 studi
- Michigan3 studi
- Minnesota4 studi
- Missouri3 studi
- New York3 studi
- Ohio3 studi
- Pennsylvania4 studi
- Tennessee3 studi
- Texas3 studi
- Washington3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Menerima pesertaFase 1/2
1 Month – 21 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Menerima pesertaFase 1
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Menerima peserta
Hingga usia 25 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT03810196Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Menerima pesertaFase 2
Hingga usia 60 · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT03314974A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Menerima pesertaFase 1
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT04024761Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Menerima pesertaFase 2
6 Months – 39 Years · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT05800210HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Menerima pesertaFase 1
Hingga usia 80 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT03326921MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Menerima pesertaFase 2
Hingga usia 60 · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT05735717Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.